Linda Humbert,Emmanuelle Proust-Lemoine,Sylvain Dubucquoi,Elisabeth Helen Kemp,Pascale Saugier-Veber,Nicole Fabien,Isabelle Raymond-Top,Catherine Cardot-Bauters,Jean-Claude Carel,Maryse Cartigny,Olivier Chabre,Philippe Chanson,Brigitte Delemer,Christine Do Cao,Laurence Guignat,Jean Emmanuel Kahn,Veronique Kerlan,Herve Lefebvre,Agnès Linglart,Roberto Mallone,Rachel Reynaud,Boualem Sendid,Pierre-François Souchon,Philippe Touraine,Jean-Louis Wémeau,Marie-Christine Vantyghem

Abstract:Abstract Background Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome is a rare disease caused by biallelic mutations of the AIRE gene, usually presenting with the triad hypoparathyroidism-adrenal failure-chronic mucocutaneous candidiasis (CMC) and nonendocrine manifestations. The aim of this study was to determine the molecular profile of the AIRE gene, the prevalence of rare manifestations, and to characterize immunological disturbances in a French cohort. Patients and Methods A national, multicenter prospective observational study to collect genetic, clinical, biological, and immunological data (NCT03751683). Results Twenty-five patients (23 families) were enrolled. Eleven distinct AIRE variants were identified, 2 of which were not previously reported: an intronic variant, c.653-70G > A, and a c.1066del (p.Arg356GlyfsX22) variant (exon 9). The most common was the Finnish variant c.769C > T (16 alleles), followed by the variant c.967_979del13 (15 alleles), which seemed associated with a less severe phenotype. Seventeen out of 25 patients were homozygote. The median number of clinical manifestations was 7; 19/25 patients presented with the hypoparathyroidism-adrenal failure-CMC triad, 8/13 showed pulmonary involvement, 20/25 had ectodermal dystrophy, 8/25 had malabsorption, and 6/23 had asplenia. Fifteen out of 19 patients had natural killer cell lymphopenia with an increase in CD4+ and CD8+ T lymphocytes and an age-dependent alteration of B lymphocyte homeostasis compared with matched controls (P < .001), related to the severity of the disease. All tested sera (n = 18) were positive for anti-interferon-α, 15/18 for anti-IL-22 antibodies, and 13/18 for anti-IL-17F antibodies, without clear phenotypic correlation other than with CMC. Conclusion This first prospective cohort showed a high AIRE genotype variability, with 2 new gene variants. The prevalence of potentially life-threatening nonendocrine manifestations was higher with systematic screening. These manifestations could, along with age-dependent B-cell lymphopenia, contribute to disease severity. Systematic screening for all the manifestations of the syndrome would allow earlier diagnosis, supporting vaccination and targeted therapeutic approaches.

High-Resolution Transcriptional Impact of AIRE: Effects of Pathogenic Variants p.Arg257Ter, p.Cys311Tyr, and Polygenic Risk Variant p.Arg471Cys

A partial form of AIRE deficiency underlies a mild form of autoimmune polyendocrine syndrome type 1

A novel AIRE mutation leads to autoimmune polyendocrine syndrome type-1

Where AIRE we now? Where AIRE we going?

Analysis of the AIRE Gene Promoter in Patients Affected by Autoimmune Polyendocrine Syndromes

A Functional Alternative Splicing Mutation In Aire Gene Causes Autoimmune Polyendocrine Syndrome Type 1

Transcriptional Changes in Regulatory T Cells From Patients With Autoimmune Polyendocrine Syndrome Type 1 Suggest Functional Impairment of Lipid Metabolism and Gut Homing

Aire‐ing Self Antigen Variability and Tolerance

A deep intronic splice–altering AIRE variant causes APECED syndrome through antisense oligonucleotide-targetable pseudoexon inclusion

Twenty Years of AIRE

Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1

Transcriptional regulation by AIRE: molecular mechanisms of central tolerance

Mechanistic dissection of dominant AIRE mutations in mouse models reveals AIRE autoregulation

The Role of Autoimmune Regulator (AIRE) in Peripheral Tolerance

Single cell characterization of blood and expanded regulatory T cells in autoimmune polyendocrine syndrome type 1

Systemic interferon type I and B cell responses are impaired in autoimmune polyendocrine syndrome type 1

Insights from a WES Investigation

Characterization of the clinical and genetic spectrum of autoimmune polyendocrine syndrome type 1 in Chinese case series

AIRE deficiency, from preclinical models to human APECED disease

Autoimmune Regulator (AIRE) Deficiency Does Not Affect Atherosclerosis and CD4 T Cell Immune Tolerance to Apolipoprotein B

Lessons From Prospective Longitudinal Follow-up of a French APECED Cohort